Quick, low-cost procedure developed for early detection of oral cancer

July 29, 2014 by Elizabeth Kuo
Credit: Katarzyna Bialasiewicz, Thinkstock

A quick and simple procedure that would allow healthcare providers to screen for early signs of oral cancer at little cost has been developed by UTS researchers.

Currently, there are no routine screening tests for . But a simple blood test could change that, helping to stem the rise globally of oral cancers such as cancer of the throat, voice box, mouth and tongue.

Dr Nham Tran and PhD candidate Samantha Khoury from UTS's Centre for Health Technologies have invented miLIFE™, a blood-based diagnostic test that looks at the profile of small molecules called microRNA to reveal the early warning signs.

The two Sydney researchers have developed an innovative blood-based test that can be easily administered by healthcare providers and is painless for the public.

The turnaround time for the entire procedure is approximately 48 hours, said Ms Khoury.

"What we are looking for in the blood sample are tiny molecules known as microRNA, which circulate in the blood," she said.

"Levels of five specific microRNA molecules are detected with miLIFE™ and compared with healthy, non-cancerous individuals. An overabundance or expression of these specific microRNAs will place you in a high risk category and you will be referred to a specialist for further examination.

Dr Nham Tran, Credit: Pamela Ajuyah

"You don't need a specialist to administer the test," she said. "When you visit your GP for routine checks of cholesterol, vitamin D, haemoglobin and so on, the same blood sample can be used to check for the presence of microRNA biomarkers."

About 300,000 new cases of oral cancer were reported globally in 2012. The main hurdles to treatment are late detection and low awareness of the disease.

Warning symptoms for oral cancer include pain, swelling, hoarse voice and difficulty swallowing – symptoms that can easily be dismissed or misdiagnosed as a common cold, said Dr Tran.

"The majority of oral cancer patients who visit the doctor have already developed an advanced lesion, but by then it is too late," said Dr Tran. "At this stage, their diagnosis option is to undergo a tumour biopsy or a fine needle aspiration, both highly invasive and painful procedures.

"We hope that through miLIFE™ we can provide early intervention to decrease the number of Australians who are diagnosed with oral cancer each year."

The test is being filed under a UTS provisional patent and Dr Tran hopes it will be available to patients within two to three years.

"This technology has been in development since 2006 and has evolved thanks to the ongoing collection of consenting cancer patient samples from surgeons based at several Sydney hospitals. Our collaborations with the Sydney Head and Neck Cancer Institute, the Cancer Council and the Mt Sinai Hospital in New York have provided valuable contributions to this study. We hope to expand this work with the Vellore Christian Medical College Foundation in India.

"This is very pertinent given India has the world's highest rates of oral cancer with 40,000 cases diagnosed each year. The introduction of a robust cancer screen will provide a platform for effective cancer management in low resourced countries."

Explore further: Dentists play key role in detecting oral cancer

Related Stories

Dentists play key role in detecting oral cancer

April 7, 2012
(HealthDay) -- Not only do regular dental exams help keep your teeth and gums healthy, they can help detect oral cancer, the Academy of General Dentistry says.

Team develops a framework for monitoring oral cancer development

June 10, 2014
Each year, approximately 22,000 Americans are diagnosed with oral cancer. The five-year survival rate of 40% in the U.S. is one of the lowest of the major cancers, and it has not improved in the past 40 years. More people ...

Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer

October 28, 2013
A new analysis has found that the presence of short segments of genetic material (known as microRNA) within papillary thyroid cancer tumors suggests a likelihood of recurrence after patients undergo surgery. The study, which ...

New hope for early detection of stomach cancer

March 17, 2014
(Medical Xpress)—University of Adelaide research has provided new hope for the early detection of stomach cancer with the identification of four new biomarkers in the blood of human cancer patients.

Researchers home in on way to predict aggressiveness of oral cancer

June 26, 2014
(Medical Xpress)—Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers ...

HPV a growing cause of upper throat cancer (Update)

June 3, 2013
Actor Michael Douglas' comments about throat cancer have thrown a spotlight on cancer risks from a sexually spread virus. The virus, HPV, is best known for causing cervical cancer. But experts say it also is a growing cause ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.